Healthcare & Medical Devices Global On demand · 24-48h

Global Home Neurofeedback Device Market Strategic Research Report

Global Home Neurofeedback Device Market Strategic Research R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Home Neurofeedback Device Market
$3112025
9.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: EEG-based, fNIRS-based, Multimodal Signal-based, Others

By Application: Healthcare, Cognitive Training, Special Populations, Sports, Scientific Research, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Narbis, Muse, Sens.ai, Mendi, NeurOptimal, FocusCalm, Myneurva, Neurosity, BrainBit, Emotiv, URGOnight, Neuphony, NeuroSky, Myndlift, Thought Technology, Mind Media, Wearable Sensing, BEE Medic, BrainCo, Neuracle, VIE, Alphatec

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 153 pages
Market size 2025
$311
Million USD
Forecast CAGR
9.5%
2025-2032
Forecast 2032
$587
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Home Neurofeedback Device market size is predicted to grow from US$ 311 million in 2025 to US$ 593 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

In 2025, global Home Neurofeedback Device production reached approximately 600 K units, with an average global market price of around 530 US$/unit.

A home neurofeedback device is a portable, non-invasive technological tool that enables individuals to receive neurofeedback therapy conveniently in their own homes, belonging to the broader neurotechnology and consumer-grade medical device category. As a form of biofeedback, it primarily uses EEG (electroencephalogram) technology or other brain activity monitoring sensors to capture real-time brainwave signals, which are then converted into visual or auditory feedback through connected smartphones, computers, or dedicated software interfaces; this feedback helps users consciously regulate and optimize their brain function, such as relieving stress, improving focus, or managing symptoms of conditions like anxiety, ADHD, and insomnia, without the need for frequent visits to professional clinics, thus offering a personalized and accessible brain training solution.

The global demand for home neurofeedback devices is growing steadily, driven by the rising global attention to mental health and wellness, the increasing preference for at-home therapy (highlighted by the post-COVID-19 emphasis on telemedicine solutions), and the growing acceptance of non-pharmacological interventions for mental health management; core audiences include young and middle-aged adults facing work-related stress, parents of children with ADHD, the elderly with sleep disorders, and health-conscious individuals pursuing cognitive enhancement, with notable demand concentration in North America, Europe, and rapidly growing markets in Asia such as China, Japan, and South Korea. This surging demand translates into substantial business opportunities: the global market size is projected to grow at a CAGR of 9.2% in the coming years, with opportunities lying in product diversification (such as developing more compact, wearable devices integrated with AI and machine learning for personalized training), channel expansion (strengthening online sales and cooperation with health platforms), and technological innovation (integrating VR/AR for immersive training or cloud connectivity for progress tracking); additionally, IP authorization, software subscription services, and remote clinical guidance supporting can further diversify revenue streams, though manufacturers need to address challenges such as high device costs, regulatory approvals, and consumer skepticism to fully tap into the market potential.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Home Neurofeedback Device market?

What factors are driving Home Neurofeedback Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Home Neurofeedback Device market opportunities vary by end market size?

How does Home Neurofeedback Device break out by Device Form Factor, by Application?

This report presents a comprehensive overview of the global Home Neurofeedback Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Technology Type

  • EEG-based
  • fNIRS-based
  • Multimodal Signal-based
  • Others

Segment by Device Form Factor

  • Wearable Devices
  • Portable Compact Devices
  • Desktop Systems
  • Others

Segment by Channel Configuration

  • Single-Channel Device
  • Dual-Channel Device
  • Multi-Channel Device

Segment by Application

  • Healthcare
  • Cognitive Training
  • Special Populations
  • Sports
  • Scientific Research
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Home Neurofeedback Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Healthcare, Cognitive Training, Special Populations evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Home Neurofeedback Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$311
2025
Forecast
$587
2032
CAGR
9.5%
2025–2032
Regionen
5
global
Key companies
NarbisMuseSens.aiMendiNeurOptimalFocusCalmMyneurvaNeurosity
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
EEG-basedfNIRS-basedMultimodal Signal-basedOthers
By Application
HealthcareCognitive TrainingSpecial PopulationsSportsScientific ResearchOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 EEG-based
  • 3.1.3 fNIRS-based
  • 3.1.4 Multimodal Signal-based
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Healthcare
  • 4.1.3 Cognitive Training
  • 4.1.4 Special Populations
  • 4.1.5 Sports
  • 4.1.6 Scientific Research
  • 4.1.7 Others
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Narbis
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Muse
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Sens.ai
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Mendi
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 NeurOptimal
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 FocusCalm
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Myneurva
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Neurosity
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 BrainBit
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Emotiv
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 URGOnight
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Neuphony
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 NeuroSky
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Myndlift
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Thought Technology
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Mind Media
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Wearable Sensing
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 BEE Medic
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 BrainCo
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Neuracle
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 VIE
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Alphatec
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Home Neurofeedback Device market?
The global Home Neurofeedback Device market is estimated at US$ 311 million in 2025 (base year) and is projected to reach US$ 593 million by 2032.
What is the forecast CAGR for the Home Neurofeedback Device market?
The market is expected to grow at a CAGR of 9.5% from 2026 to 2032, expanding from US$ 311 million in 2025 to US$ 593 million in 2032, roughly 1.9 times its base-year value.
What is Home Neurofeedback Device?
In 2025, global Home Neurofeedback Device production reached approximately 600 K units, with an average global market price of around 530 US$/unit.
How is the Home Neurofeedback Device market segmented by technology type?
By technology type, the market is segmented into EEG-based, fNIRS-based, Multimodal Signal-based and Others.
What are the key applications of Home Neurofeedback Device?
Key applications covered include Healthcare, Cognitive Training, Special Populations, Sports, Scientific Research and Others.
Which companies are profiled in the Home Neurofeedback Device market report?
Key players profiled include Narbis, Muse, Sens.ai, Mendi, NeurOptimal, FocusCalm, Myneurva and Neurosity, among 22 companies covered in total.
What geographies does the Home Neurofeedback Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Home Neurofeedback Device?
What factors are driving Home Neurofeedback Device market growth, globally and by region?
Who should buy the Home Neurofeedback Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Healthcare, Cognitive Training and Special Populations, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Home Neurofeedback Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.